Considering that AP-1 controls the transcription of the KCa3.1 gene KCNN4 [18] and that IL-4/IL-4R signaling regulates KCa3.1 expression through the activation of the AP-1 transcription factor [19], this signaling could be relevant upon GBM radiation. The gene discussed is KCNN4; the disease is glioblastoma.